General Dermatology

AAD honors Henry W. Lim, MD, FAAD, with the Academy's highest honor for his work in photodermatology advances, skin of color care, and global leadership.

Hoth Therapeutics has received regulatory approval in Hungary to expand the phase 2 trial into Europe, with Spain and Poland approvals anticipated.

LPP affects roughly 100,000 adults in the US and currently has no FDA-approved treatments.

Daniel C. Butler, MD, discusses the underrepresentation of older adults in dermatology trials and what a 3-system framework for itch means for clinical practice

Dermatology Times is looking back on the top stories in dermatology from the month of March.

Learn more about the in-depth topics covered in the March 2026 print issue of Dermatology Times.

Dermatology Times is recapping our exclusive expert interviews from the month of March.

Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.

At AAD 2026, Maria-Angeliki Gkini, MD, PhD, shared guidance on diagnosing and managing topical steroid withdrawal syndrome.

Daniel C. Butler, MD, discusses adherence challenges, medication risks, and practical strategies to optimize dermatologic care in older adults.

This year’s AAD poster awards highlight studies advancing skin cancer prevention, inflammatory disease management, and complex dermatology care.

These leaders are shaping the future of dermatology through their clinical expertise, research, and educational presentations.

Guardrails and disclaimers are essential for responsible AI deployment in dermatology, according to Faranak Kamangar, MD.

Who is a woman who has shaped your life and career in dermatology? Hear stories from our experts as we celebrate Women's History Month 2026.

Overall, the future of dermatology lies in integrating innovation with individualized, evidence-based, and patient-centered care.

Twin experts reveal how dermatology and dentistry team up for facial aesthetics, early lesion detection, and safer care—from lasers to oral screenings.

In case you missed it, this week we had news on the FDA's approval of icotrokinra, phase 3 ADorable-1 data supporting lebrikizumab, the sBLA acceptance of tildrakizumab for PsA, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Aging hair fibers become finer in diameter, increasing vulnerability to chemical and physical damage.

When used thoughtfully, Faranak Kamangar, MD, says AI can transform generic processes into innovative, time-saving clinical tools.

Defined by emotional exhaustion, depersonalization, and reduced accomplishment, burnout goes beyond a difficult day in clinic.

Discover how physician-led dermatology practices build patient-first culture, drive innovation, and sustain long-term care in a changing health care market.

Women often present with sudden skin, hair, and vascular changes that may signal perimenopause rather than normal aging.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news on deucravacitinib's approval for PsA, AI-based tumor shape analysis in melanoma, QRX003's fast track for Netherton Syndrome, and more.